Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $17.7 Million - $20 Million
-306,302 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $10 Million - $11.1 Million
174,625 Added 132.62%
306,302 $689,000
Q2 2020

Aug 06, 2020

BUY
$54.82 - $64.09 $7.22 Million - $8.44 Million
131,677 New
131,677 $471,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ovata Capital Management LTD Portfolio

Follow Ovata Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ovata Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ovata Capital Management LTD with notifications on news.